Search results
CORRECTED-FOREX-Firm dollar drags yen down closer to intervention range
Reuters via Yahoo Finance· 6 days agoA firm U.S. dollar had the yen locked near a fresh 34-year low on Tuesday, keeping investors on heightened intervention watch as they looked ahead to key U.S. inflation report and the Bank of ...
Roche eyes return to growth after Q1 hit by forex, loss of COVID sales
Reuters· 5 days ago, opens new tab confirmed ambitions to return to sales growth this year on a continued boost from...
5 Best Online Stock Brokers in Australia for 2024 • Benzinga
Benzinga· 5 days agoAccording to current market estimates, the premier stock market in Australia (the Australian Securities Exchange or “ASX” for short) sees an average daily turnover of over ...
BOJ to Hold Rates With Focus on Hawkish Signals to Buoy Yen
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- The Bank of Japan is widely expected to leave its benchmark interest rate unchanged...
USD/INR halts its rally ahead of US PCE data
The Forex Market· 3 days agoIndian Rupee (INR) extends the rally on Friday, bolstered by interbank US Dollar (USD) sales.
How Mt.Gox’s looming $9 billion payout could impact Bitcoin | Invezz
Invezz· 5 days agoMt.Gox is likely to distribute the 142,000 Bitcoin that it owes to creditors, in the coming weeks....
Dollar weakness seen as short-lived amid economic data
Investing.com· 5 days agoDollar weakness seen as short-lived amid economic data
USD/INR extends recovery ahead of US GDP data
The Forex Market· 4 days agoIndian Rupee (INR) extends its downside on Thursday despite the decline of the US Dollar (USD).
Week Ahead for FX, Bonds: Focus on Fed Decision, U.S. Jobs Data and Weak Japanese Yen
Morningstar· 8 hours agoBelow are the most important global events likely to affect FX and bond markets in the coming week starting April 29. The U.S. Federal Reserve's monetary policy decision on Wednesday is likely ...
UPDATE 2-Roche eyes return to growth after Q1 hit by forex, loss of COVID sales
Reuters via Yahoo Finance· 5 days agoRoche confirmed ambitions to return to sales growth this year on a continued boost from eye drug Vabysmo, after first-quarter sales slipped by 6% on the loss on COVID-19-related revenue. Quarterly ...